Table 1

Summary of secondary outcomes at baseline and 4 and 12 months follow-up and analysis of between group differences at 12 months

Baseline4-month follow-up12-month follow-upBetween group difference or OR at 12 months*
Mean (95% CI) P value
Control Mean (SD) Median (IQR) or n/N (%)Intervention Mean (SD) Median (IQR) or n/N (%)Control Mean (SD) Median (IQR) or n/N (%)Intervention Mean (SD) Median (IQR) or n/N (%)Control Mean (SD) Median (IQR) or n/N (%)Intervention Mean (SD) n, Median (IQR) or n/N (%)
Achievement of at least 150 min of weekly MVPA in ≥10 min bouts†8/201 (4%)9/207 (4%)2/128 (2%)7/109 (6%)3/133 (2%)6/110 (5%)OR: 3.80 (0.16 to 20.92), 0.12
Achievement of at least 150 min of weekly MVPA†149/201 (74%)178/207 (86%)98/128 (76%)99/109 (91%)99/133 (74%)93/110 (85%)OR: 1.67 (0.82 to 3.42), 0.16
Self-reported MVPA weekly minutesN=220, 213.5 (352.7)
65.0 (0–285.0)
N=220, 204.0 (375.6)
47.5 (0–247.5)
N=183, 318.0 (517.6)
95.7 (0–305.2)
N=166, 306.1 (430.5)
105.0 (0–314.1)
N=170, 228.3 (424.4)
85.0 (0–285.0)
N=154, 252.7 (426.2)
130.0 (0–320.2)
49.3 (−36.3 to 135.0) 0.26
Achievement of at least 150 min of weekly MVPA self-reported83/220 (37%)77/220 (48%)94/183 (51%)88/166 (53%)76/170 (45%)76/154 (49%)OR: 1.23 (0.79 to 1.90), 0.36
Average daily diurnal inactivity (hours)†N=199, 1.7 (1.1)N=205,
1.5 (1.1)
N=125, 1.4 (1.1)N=109,
1.4 (0.9)
N=99, 1.4 (1.0)N=78,
1.5 (1.0)
0.6 (0.5 to 0.7),<0.0001
Average daily sleep (hours)†N=199, 6.8 (1.5)N=205,
6.9 (1.2)
N=125,
6.7 (1.3)
N=109,
6.7 (1.4)
N=128,
6.8 (1.5)
N=110,
7.0 (1.5)
0.3 (−0.1 to 0.6), 0.11
EQ-5D-5L (Devlin values)N=216, 0.74 (0.24)N=215,
0.76 (0.23)
N=162, 0.72 (0.26)N=148,
0.76 (0.25)
N=158, 0.72 (0.26)N=138,
0.73 (0.27)
0.00 (−0.4 to 0.05) 0.89
HADS-DN=217, 7.6 (4.5)N=214,
7.4 (4.7)
N=164,
7.4 (4.8)
N=147,
6.0 (4.7)
N=156, 7.1 (4.8)N=139,
6.3 (5.1)
−0.2 (−1.0 to 0.6), 0.44
HADS-AN=217, 8.7 (4.6)N=214,
8.6 (5.1)
N=164, 8.5 (4.8)N=146,
7.5 (5.0)
N=156,
8.4 (4.8)
N=139,
7.6 (5.2)
−0.5 (−1.2 to 0.2), 0.20
  • Median (IQR) reported for accelerometry and self-report continuous PA outcomes only.

  • *Adjusted for baseline MVPA, age, gender, site and minimisation variables.

  • †Non-bouted accelerometer recorded MVPA adjusted for baseline outcome value, age, gender, site and minimisation variables.

  • HADS-A, Hospital Anxiety & Depression Scale - Anxiety; HADS-D, Hospital Anxiety & Depression Scale - Depression; MVPA, moderate-to-vigorous physical activity.